Chargement en cours...
Alzheimer's drug-development pipeline: 2016
BACKGROUND: Alzheimer's disease (AD) is growing in frequency and new therapies are urgently needed. METHODS: We assessed clinicaltrials.gov (accessed 1-4-2016) to determine the number and characteristics of trials in phase I, phase II, and phase III for treatment of AD. RESULTS: There are curre...
Enregistré dans:
| Publié dans: | Alzheimers Dement (N Y) |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5651348/ https://ncbi.nlm.nih.gov/pubmed/29067309 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2016.07.001 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|